RecruitingNCT06643741
Non-Invasive Preeclampsia Screening and Biobank
Collection of Pregnancy Outcome Data and Whole Blood Samples From Women Undergoing Non-Invasive Screening for Early, Preterm, and Term Preeclampsia
Sponsor
Sequenom, Inc.
Enrollment
6,550 participants
Start Date
Feb 2, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is collecting blood samples and health data from pregnant women in their first trimester to develop and validate better non-invasive tests for predicting preeclampsia (a dangerous complication of pregnancy involving high blood pressure).
**You may be eligible if...**
- You are female and 18 years or older
- You are between 11 and 14 weeks pregnant with a single baby
- You agree to blood draws at each trimester and to share your prenatal and postnatal health data
- You are willing to have specific measurements taken at your routine first-trimester ultrasound
**You may NOT be eligible if...**
- You are unlikely to return for second and third trimester visits
- Your pregnancy outcome data is unlikely to be available
- You are already enrolled in a study involving aspirin or taking unknown doses of aspirin
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06643741
Related Trials
Endothelial Dysfunction for Prognosis In Patients With preeClampSia
NCT069124771 location
A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia
NCT07463898
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters
NCT0671624211 locations
Cardiometabolic Disease and Substrate Metabolism
NCT075657271 location
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT029890251 location